pmc logo imageJournal ListSearchpmc logo image
Logo of jnnpsycJournal URL: redirect3.cgi?&&auth=0pIVI3YnvXVV5mmQpA9GLXfkdzOCQKYlvxCc9gkWb&reftype=publisher&artid=1073122&article-id=1073122&iid=116356&issue-id=116356&jid=171&journal-id=171&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://jnnp.bmj.com/
J Neurol Neurosurg Psychiatry. 1994 September; 57(9): 1026–1033.
PMCID: PMC1073122
CSF concentration gradients of monoamine metabolites in patients with hydrocephalus.
J Malm, B Kristensen, J Ekstedt, and P Wester
Department of Neurology, University Hospital of Northern Sweden, Umeå.
Abstract
Concentration gradients of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and 3-methoxy-4-hydroxyphenylglycol (MHPG), were assessed in 762 successive CSF fractions (2 ml lumbar CSF) from 15 patients with the adult hydrocephalus syndrome (AHS) and 11 patients with hydrocephalus of other causes (mixed group). A mean volume of 49.6 (SD 11.8) ml CSF was removed in the AHS group and 56.4 (10.2) ml in the mixed group. The CSF was collected with a specially designed carousel fraction collector and the corresponding CSF dynamics were continuously registered by a constant pressure CSF infusion method. Pronounced gradients in CSF HVA and CSF 5-HIAA were seen in both patient groups in the first 25 ml of CSF removed. The concentration curves levelled off, despite the removal of larger amounts of CSF and stabilised at about twice the initial concentrations. This phenomenon has not been described before. Concentrations of HVA and 5-HIAA in the first CSF fraction correlated strongly with concentrations in fractions up to about 40 ml. A positive correlation between the first fraction of CSF HVA and CSF 5-HIAA concentrations and CSF outflow conductance was found in the AHS group. There was no gradient in MHPG. It is suggested that the rostrocaudal gradients in CSF HVA and 5-HIAA may be explained by a downward flow of CSF along the spinal cord with absorption of metabolites occurring during passage. Mixing of CSF from different CSF compartments, extraventricular production sites of CSF, clearance of metabolites to venous blood or extracellular fluid, and CSF outflow conductance are probably important determinants of the plateau phase in patients with hydrocephalus. It is concluded that lumbar CSF does not exclusively reflect the concentrations of HVA, 5-HIAA, or MHPG in the ventricles. It should be noted that these results obtained in patients with hydrocephalus may not be applicable to other groups of patients or normal subjects.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Davis, KL; Kahn, RS; Ko, G; Davidson, M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991 Nov;148(11):1474–1486. [PubMed]
  • McDonald, WM; Nemeroff, CB. Neurotransmitters and neuropeptides in Alzheimer's disease. Psychiatr Clin North Am. 1991 Jun;14(2):421–442. [PubMed]
  • Davis, BA. Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects. J Chromatogr. 1989 Apr 19;466:89–218. [PubMed]
  • Gottfries, CG. Brain monoamines and their metabolites in dementia. Acta Neurol Scand Suppl. 1990;129:8–11. [PubMed]
  • Andersson, H; Roos, BE. 5-hydroxyindoleacetic acid in cerebrospinal fluid of hydrocephalic children. Acta Paediatr Scand. 1969 Nov;58(6):601–608. [PubMed]
  • Wester, P; Bergström, U; Eriksson, A; Gezelius, C; Hardy, J; Winblad, B. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem. 1990 Apr;54(4):1148–1156. [PubMed]
  • Moir, AT; Ashcroft, GW; Crawford, TB; Eccleston, D; Guldberg, HC. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain. 1970;93(2):357–368. [PubMed]
  • Stanley, M; Traskman-Bendz, L; Dorovini-Zis, K. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci. 1985 Oct 7;37(14):1279–1286. [PubMed]
  • Garelis, E; Young, SN; Lal, S; Sourkes, TL. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Brain Res. 1974 Oct 11;79(1):1–8. [PubMed]
  • Wood, JH. Neurochemical analysis of cerebrospinal fluid. Neurology. 1980 Jun;30(6):645–651. [PubMed]
  • Sjöström, R; Ekstedt, J; Anggård, E. Concentration gradients of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1975 Jul;38(7):666–668. [PubMed]
  • Bertilsson, L; Asberg, M; Lantto, O; Scalia-Tomba, GP; Träskman-Bendz, L; Tybring, G. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls. Psychiatry Res. 1982 Feb;6(1):77–83. [PubMed]
  • Young, SN; Gauthier, S; Anderson, GM; Purdy, WC. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry. 1980 May;43(5):438–445. [PubMed]
  • Ziegler, MG; Wood, JH; Lake, R; Kopin, IJ. Norepinephrine and 3-methoxy-4-hydroxyphenyl glycol gradients in human cerebrospinal fluid. Am J Psychiatry. 1977 May;134(5):565–568. [PubMed]
  • Tyce, GM; Messick, JM; Yaksh, TL; Byer, DE; Danielson, DR; Rorie, DK. Amine sulfate formation in the central nervous system. Fed Proc. 1986 Jul;45(8):2247–2253. [PubMed]
  • Siever, L; Kraemer, H; Sack, R; Angwin, P; Berger, P; Zarcone, V; Barchas, J; Brodie, HK. Gradients of biogenic amine metabolites in cerebrospinal fluid. Dis Nerv Syst. 1975 Jan;36(1):13–16. [PubMed]
  • Gateless, D; Stanley, M; Träskman-Bendz, L; Gilroy, J. The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar cerebrospinal fluid. Biol Psychiatry. 1984 Nov;19(11):1585–1589. [PubMed]
  • Scheinin, M; Seppala, T; Koulu, M; Linnoila, M. Determination of conjugated dopamine in cerebrospinal fluid from humans and non-human primates with high performance liquid chromatography using electrochemical detection. Acta Pharmacol Toxicol (Copenh). 1984 Aug;55(2):88–94. [PubMed]
  • Jakupcević, M; Lacković, Z; Stefoski, D; Bulat, M. Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of man. J Neurol Sci. 1977 Mar;31(2):165–171. [PubMed]
  • Eccleston, D; Ashcroft, GW; Crawford, TB. Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. J Neurol Neurosurg Psychiatry. 1970 Apr;33(2):269–272. [PubMed]
  • Garelis, E; Sourkes, TL. Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man. J Neurol Neurosurg Psychiatry. 1974 Jun;37(6):704–710. [PubMed]
  • Ekstedt, J. CSF hydrodynamic studies in man. 1. Method of constant pressure CSF infusion. J Neurol Neurosurg Psychiatry. 1977 Feb;40(2):105–119. [PubMed]
  • McKhann, G; Drachman, D; Folstein, M; Katzman, R; Price, D; Stadlan, EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. [PubMed]
  • Malm, J; Kristensen, B; Markgren, P; Ekstedt, J. CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study. Neurology. 1992 Apr;42(4):851–858. [PubMed]
  • Wester, P; Gottfries, J; Winblad, B. Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations. J Chromatogr. 1987 Apr 10;415(2):275–288. [PubMed]
  • Wester, P; Gottfries, J; Winblad, B. Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations. J Chromatogr. 1987 Apr 10;415(2):275–288. [PubMed]
  • Maillot, C. The perispinal spaces. Constitution, organization and relations with the cerebrospinal fluid (CSF). J Neuroradiol. 1991;18(1):18–31. [PubMed]
  • Sato, O; Asai, T; Amano, Y; Hara, M; Tsugane, R; Yagi, M. Extraventricular origin of the cerebrospinal fluid: formation rate quantitatively measured in the spinal subarachnoid space of dogs. J Neurosurg. 1972 Mar;36(3):276–282. [PubMed]
  • Lux, WE, Jr; Fenstermacher, JD. Cerebrospinal fluid formation in ventricles and spinal subarachnoid space of the rhesus monkey. J Neurosurg. 1975 Jun;42(6):674–678. [PubMed]
  • Gjerris, A; Werdelin, L; Gjerris, F; Sørensen, PS; Rafaelsen, OJ; Alling, C. CSF-amine metabolites in depression, dementia and in controls. Acta Psychiatr Scand. 1987 Jun;75(6):619–628. [PubMed]
  • Chase, TN; Gordon, EK; Ng, LK. Norepinephrine metabolism in the central nervous system of man: studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in cerebrospinal fluid. J Neurochem. 1973 Sep;21(3):581–587. [PubMed]
  • Karoum, F; Moyer-Schwing, J; Potkin, SG; Wyatt, RJ. Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma. Brain Res. 1977 Apr 15;125(2):333–339. [PubMed]
  • Ashcroft, GW; Crawford, TB; Eccleston, D; Sharman, DF; MacDougall, EJ; Stanton, JB; Binns, JK. 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet. 1966 Nov 12;2(7472):1049–1052. [PubMed]
  • Fridén, HG; Ekstedt, J. Volume/pressure relationship of the cerebrospinal space in humans. Neurosurgery. 1983 Oct;13(4):351–366. [PubMed]
  • Grant, R; Condon, B; Hart, I; Teasdale, GM. Changes in intracranial CSF volume after lumbar puncture and their relationship to post-LP headache. J Neurol Neurosurg Psychiatry. 1991 May;54(5):440–442. [PubMed]
  • McComb, JG. Recent research into the nature of cerebrospinal fluid formation and absorption. J Neurosurg. 1983 Sep;59(3):369–383. [PubMed]
  • Oresković, D; Whitton, PS; Lupret, V. Effect of intracranial pressure on cerebrospinal fluid formation in isolated brain ventricles. Neuroscience. 1991;41(2-3):773–777. [PubMed]
  • Ashcroft, GW; Dow, RC; Moir, AT. The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog. J Physiol. 1968 Dec;199(2):397–425. [PubMed]
  • Van der Poel, FW; Van Praag, HM; Korf, J. Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space. Psychopharmacology (Berl). 1977 Mar 23;52(1):35–40. [PubMed]
  • Folstein, MF; Folstein, SE; McHugh, PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. [PubMed]
  • Hachinski, VC; Iliff, LD; Zilhka, E; Du Boulay, GH; McAllister, VL; Marshall, J; Russell, RW; Symon, L. Cerebral blood flow in dementia. Arch Neurol. 1975 Sep;32(9):632–637. [PubMed]